Welcome to our dedicated page for Visionary Holdings news (Ticker: GV), a resource for investors and traders seeking the latest updates and insights on Visionary Holdings stock.
Visionary Holdings Inc. reports developments tied to its healthcare, biotechnology, and medical-aesthetics focus, including commercialization activity for anti-aging and regenerative wellness products. Company updates have covered V-series anti-aging products, RAMU-related products, Premier Regenerative Complex-President Super Injection, distribution arrangements, channel development, and healthcare service collaborations in markets including China.
Recurring news also includes Nasdaq listing-compliance matters for GV common shares, periodic reporting status, listing-fee notices, shareholder voting matters, governance actions, capital-structure disclosures, and operating and financial results.
Visionary Holdings has announced its collaboration with Canada's B. Braun Biochip Technology Group to establish Visionary Biotechnology Group in Toronto. This partnership aims to leverage world-class biochip technology, addressing substantial market gaps in Canada and China. B. Braun has invested nearly $150 million in biochip development over the last decade, cooperating with renowned medical institutions. The new factory in China, a $300 million investment, will begin production in March 2025, with an anticipated five-year output value of over $3 billion. Visionary's biochip products serve multiple fields, including medical testing, drug R&D, animal quarantine, and cold chain transport, highlighting their broad application and market potential.
Visionary Holdings (NASDAQ: GV), a private education provider focused on AI and life sciences, announced the appointment of Zhong Chen as the new CFO, effective May 6, 2024. The decision follows the resignation of former CFO Katy Liu on February 9, 2024, which wasn't due to any disagreements with the company. Mr. Chen, who is also the CEO, brings extensive experience in multinational enterprise project development, operational management, and capital operations to his new role.
Visionary Holdings (NASDAQ: GV), a leading private education provider specializing in AI and life science technology, celebrated its second anniversary of listing on May 8, 2024. The event highlighted the company's achievements and honored key contributors, including Ms. Zhang Xiaohua, who received the highest honor of the evening. Visionary has made notable progress over the past two years, focusing on innovation and sustainable development. The company remains committed to technological advancements and providing high-quality services. Looking forward, Visionary aims to continue its growth and contribute more to society through ongoing collaboration and innovation.
Visionary Holdings (NASDAQ: GV), a private education provider with a focus on AI and life sciences, celebrated its second anniversary of listing on May 8, 2024. The gala recognized partners and supporters, with Ms. Xiaohua Zhang receiving top honors and a Farnova Coupe. Visionary highlighted its innovation, excellence, and sustainable development over the past two years and acknowledged key partners from various sectors who contributed to its growth. The company remains optimistic about its future, emphasizing continuous innovation and collaboration.
Visionary Holdings Inc. successfully transitioned from traditional education to high-tech, life sciences, and AI education, with a focus on expanding into new energy vehicles, bio technology, life science industry, and STEM-AI education. The company hosted a global news conference in Toronto with prominent guests and government representatives praising their accomplishments. Visionary has formed strategic partnerships with Farnova Holding Group, Canada BRAUN Bio Technology Group Inc., Zhejiang Ruikun Technology Group, and Red Sun Group to develop cutting-edge products and expand into new markets.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.